Quarterly Net Profit at Rs. 191.71 crore in March 2025 up 3.01% from Rs. 186.10 crore in March 2024. EBITDA stands at Rs. 225 ...

Donald Niedekker’s evocative fictional reckoning with the expedition, “Strange and Perfect Account From the Permafrost,” is ...

Quarterly Net Profit at Rs. 151.86 crore in March 2025 up 3.86% from Rs. 146.22 crore in March 2024. EBITDA stands at Rs. 221.05 crore in March 2025 up 5.95% from Rs. 208.64 crore in March 2024.

If your school is open: contact the school directly to access your records. You can view the school's entry in the online version of Vision and Realisation: a ...

Don't miss out on the headlines from NRL. Followed categories will be added to My News. The amicable split comes off the back of Taupau liking a social media post by retired Kiwis player Elijah ...

Broncos coach Michael Maguire has addressed veteran prop Martin Taupau’s sudden exit from the club, with both parties agreeing to part ways immediately following the fallout from a social media ...

Jim Callis officially ushered in mock draft season a little over a week ago. Now it’s my turn to take the wheel for the first time this spring. While we still have a long way to go and there’s a ton ...

ETMarkets.com Dr Reddy's Labs shares: The company posted a 22% year-on-year increase in consolidated net profit, reaching Rs 1,594 crore. Dr Reddy's Laboratories shares will be in focus on Monday ...

Its net earnings increased 22% over the last corresponding quarter. Dr. Reddy’s made a profit of ₹1,594 crore for this quarter, versus a profit of ₹1,307 crores for the last year.

Hyderabad-based Dr Reddy’s Laboratories (DRL) posted a 22 per cent year-on-year (Y-o-Y) rise in consolidated profit after tax (PAT) for the fourth quarter of 2024-25 at ₹1,593.9 crore. Revenues for ...

Dr Reddy’s Laboratories on Thursday reported a consolidated net profit of ₹1,593.9 crore for the quarter ended March 31, 2025 (Q4 FY25), marking a 22 per cent increase year-on-year (Y-o-Y) from ₹1,307 ...

Dr Reddy's Laboratories on Friday reported a consolidated net profit growth of 22% to Rs 1,594 crore in Q4FY25 versus Rs 1,307 crore reported in the year ago period. The pharma major's revenue from ...